These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 34826317)

  • 1. Corrigendum to "Efficacy of evocalcet in previously cinacalcet-treated secondary hyperparathyroidism patients," [
    Koiwa F; Tokunaga S; Asada S; Endo Y; Fukagawa M; Akizawa T
    Kidney Int Rep; 2021 Nov; 6(11):2936-2937. PubMed ID: 34826317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corrigendum to "The Cumulative Rate of SARS-CoV-2 Infection in Chinese Hemodialysis Patients" [Kidney Int. Rep. 2020 1416-1421].
    Xu X; Nie S; Sun J; Kong Y; Liang M; Li D; Ma T; Peng J; Gao S; Shao Y; Zha Y; Peng G; Ren C; Huang A; Hou FF
    Kidney Int Rep; 2021 Sep; 6(9):2525. PubMed ID: 34490410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to "Transjugular Kidney Biopsy as a Safe Method to Increase the Etiological Diagnosis in Kidney Disease"
    Cardona MB; Soler MJ; McMahon GM
    Kidney Int Rep; 2021 Dec; 6(12):3095. PubMed ID: 34901580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum to "Narita I. Estimating Growth Rate by a Single Measurement of Kidney Volume in ADPKD."
    Kidney Int Rep; 2021 Feb; 6(2):552. PubMed ID: 33615083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum to "Vimala, A. Hyponatremia among patients admitted in critical care unit at tertiary care hospitals."
    Kidney Int Rep; 2020 Jun; 5(6):959. PubMed ID: 36409160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum to "Luyckx VA, Cherney DZI, Bello AK. Preventing CKD in Developed Countries."
    Kidney Int Rep; 2020 May; 5(5):758. PubMed ID: 32405601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corrigendum to "Successful Urine Multiplex Bead Assay to Measure Lupus Nephritis Activity"
    Cody EM; Bennett MR; Gulati G; Ma Q; Altaye M; Devarajan P; Brunner HI
    Kidney Int Rep; 2021 Oct; 6(10):2735. PubMed ID: 34622116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum to "Kimura T, Snijder R, Nozaki K. Diagnosis patterns of CKD and anemia in the Japanese population."
    Kidney Int Rep; 2020 Sep; 5(9):1614. PubMed ID: 32954091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum to Davies SJ, Zhao J, Morgenstern H, et al. Low Serum Potassium Levels and Clinical Outcomes in Peritoneal Dialysis-International Results from PDOPPS.
    Kidney Int Rep; 2021 May; 6(5):1485. PubMed ID: 34013134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum to Shi M, Yu S, Ouyang Y, et al. Increased lifetime risk of ESRD in familial IgA nephropathy.
    Kidney Int Rep; 2021 May; 6(5):1484. PubMed ID: 34013133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum to "Cataldo E, Cinquantini F, Priola AM, et al. Spontaneous renal artery dissection in Ehler-Danlos syndrome."
    Kidney Int Rep; 2020 Mar; 5(3):382. PubMed ID: 32154462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrigendum to "Morales-Alvarez MC, Garcia-Dolagaray G, Millan-Fierro A, Rosas SE. Renal function decline in Latinos with type 2 diabetes."
    Kidney Int Rep; 2020 Jul; 5(7):1121. PubMed ID: 32647776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Head-to-head comparison of the new calcimimetic agent evocalcet with cinacalcet in Japanese hemodialysis patients with secondary hyperparathyroidism.
    Fukagawa M; Shimazaki R; Akizawa T;
    Kidney Int; 2018 Oct; 94(4):818-825. PubMed ID: 30049473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum to Inaba M, Une Y, Ikejiri K, et al. "Dose-Response of Tenapanor in Patients With Hyperphosphatemia Undergoing Hemodialysis in Japan-A Phase 2 Randomized Trial."
    Kidney Int Rep; 2022 Jul; 7(7):1729. PubMed ID: 35812270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum to Gathmyr D, Maruhum Bonar M, Susilo A, Harimurti K. "The relationship between IL-6, IL-10, TNF-α with AKI in moderate and severe COVID-19 patients [abstract POS-014]."
    Kidney Int Rep; 2022 Apr; 7(4):935. PubMed ID: 35285608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum to Ng MS, Malacova E, Hurst C, David MC, Johnson DW, Mallett AJ. "Clinical Outcomes of People With Fabry Disease - ANZDATA Registry Study."
    Ng MS; Malacova E; Hurst C; David MC; Johnson DW; Mallett AJ
    Kidney Int Rep; 2022 Mar; 7(3):664. PubMed ID: 35257086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum to "Zand L, Canetta P, Lafayette R, et al. An open-label pilot study of adrenocorticotrophic hormone in the treatment of IgA nephropathy at high risk of progression."
    Kidney Int Rep; 2020 Mar; 5(3):382. PubMed ID: 32154464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corrigendum to "Boudard D, Aureli F, Laurent B, et al. Chronic oral exposure to synthetic amorphous silica (NM-200) results in renal and liver lesions in mice."
    Kidney Int Rep; 2020 Mar; 5(3):382. PubMed ID: 32154463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Evocalcet in Previously Cinacalcet-Treated Secondary Hyperparathyroidism Patients.
    Koiwa F; Tokunaga S; Asada S; Endo Y; Fukagawa M; Akizawa T
    Kidney Int Rep; 2021 Nov; 6(11):2830-2839. PubMed ID: 34805635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corrigendum to Nishank Jain, Milind A. Phadnis, Suzanne L. Hunt, Junqiang Dai, Theresa I. Shireman, Clayton L. Davis, Jawahar L. Mehta, Rafia S. Rasu and S. Susan Hedayati. "Comparative Effectiveness and Safety of Oral P2Y12 Inhibitors in Patients on Chronic Dialysis".
    Kidney Int Rep; 2022 Oct; 7(10):2321. PubMed ID: 36217521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.